Press release
United States Weight Loss Therapeutics Market to Grow at 20.6% CAGR through 2033, Driven by Surging Demand for GLP-1 Agonists and Next-Gen Prescription Drugs | DataM Intelligence
Weight loss therapeutics Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/weight-loss-therapeutics-market?jd
United States Key Industry Developments
☑️ January 2026: Novo Nordisk expanded manufacturing capacity for Wegovy (semaglutide), addressing supply constraints and securing additional formulary placements across major U.S. payers amid surging demand.
☑️ January 2026: Eli Lilly reported accelerated uptake of Zepbound (tirzepatide), with new real-world evidence demonstrating superior weight loss outcomes in obese patients with comorbidities.
☑️ December 2025: Rhythm Pharmaceuticals advanced its setmelanotide program for rare genetic obesity, gaining traction in pediatric and specialty clinics following expanded FDA approvals.
☑️ December 2025: Currax Pharmaceuticals strengthened distribution partnerships for Contrave, targeting retail pharmacy channels to reach broader overweight populations.
Japan Key Industry Developments
☑️ January 2026: Japanese regulatory authorities fast-tracked reviews for GLP-1-based therapies, with Novo Nordisk and Eli Lilly preparing launches of semaglutide and tirzepatide injections for obesity management.
☑️ January 2026: Local healthcare providers showcased integrated weight loss programs incorporating prescription drugs and natural supplements at major endocrinology conferences in Tokyo.
☑️ December 2025: Growing adoption of oral anti-obesity medications and injectables in urban clinics, driven by increasing obesity rates and government focus on metabolic health.
Key Mergers and Acquisitions
✦ Eli Lilly announced a strategic collaboration and potential acquisition discussions in the GLP-1 space to further strengthen its oral and dual-agonist pipeline for weight loss (January 2026).
✦ Novo Nordisk continued expansion through targeted bolt-on acquisitions of delivery technology firms to enhance next-generation injectable and oral formulations for obesity therapeutics.
✦ GSK secured a licensing agreement with a biotech innovator to advance novel oral anti-obesity candidates, positioning for entry into the high-growth prescription segment in early 2026.
Purchase the report to unlock market insights:
https://www.datamintelligence.com/buy-now-page?report=weight-loss-therapeutics-market
Market Segmentation Analysis
By Therapeutics: Prescription Drugs dominate (valued at US$ 1.79 billion in 2024); followed by Over-the-Counter, Natural Supplements, and Others.
By Condition: Obesity holds the largest share; followed by Overweight and Others.
By Dosage Form: Injectables lead due to GLP-1 efficacy; followed by Tablets, Capsules, and Others.
By Distribution Channel: Retail Pharmacies and Online Pharmacies grow rapidly; Hospital Pharmacies remain key for specialty prescriptions.
Regional Insights
North America commands the largest market share in the global Weight Loss Therapeutics market, valued at US$ 1.54 billion in 2024, supported by high obesity rates, widespread adoption of GLP-1 agonists like semaglutide and tirzepatide, favorable reimbursement policies, strong clinical evidence, and the presence of leading innovators driving prescription volume and patient access. Asia-Pacific remains the fastest-growing region, fueled by rapidly rising obesity prevalence in emerging economies, increasing healthcare spending, expanding availability of branded and generic anti-obesity drugs, growing online pharmacy penetration, and aggressive market entry by global players.
Growth Drivers
✦ Explosive global rise in obesity and overweight populations
✦ Breakthrough efficacy of GLP-1 and dual GIP/GLP-1 receptor agonists
✦ Rapid prescription growth and supply chain improvements for semaglutide and tirzepatide
✦ Increasing consumer demand for convenient oral and injectable options
✦ Pipeline innovation, regulatory approvals, and expanding distribution channels
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/weight-loss-therapeutics-market?jd
Key Players
The market includes leading companies such as Novo Nordisk A/S, Currax Pharmaceuticals LLC, Eli Lilly and Company, VIVUS LLC, Rhythm Pharmaceuticals, Inc., CHEPLAPHARM GmbH, GSK plc, KVK Tech, Inc., Teva Pharmaceutical Industries Ltd, and others.
Key Highlights (Top 5 Key Players)
✦ Novo Nordisk A/S - Leading with Wegovy and Ozempic dominance in the GLP-1 category.
✦ Eli Lilly and Company - Driving growth through Zepbound and Mounjaro's superior dual-agonist efficacy.
✦ Rhythm Pharmaceuticals, Inc. - Specializing in rare genetic obesity treatments with setmelanotide.
✦ GSK plc - Advancing oral anti-obesity candidates and broad portfolio expansion.
✦ Currax Pharmaceuticals LLC - Strong in Contrave for comprehensive weight management.
Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd
Power your decisions with real time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Weight Loss Therapeutics Market to Grow at 20.6% CAGR through 2033, Driven by Surging Demand for GLP-1 Agonists and Next-Gen Prescription Drugs | DataM Intelligence here
News-ID: 4341626 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Payment Processing Solutions Market to Reach US$ 198.9 Billion by 2034 at 11.7% …
The Global Payment Processing Solutions Market reached approximately US$ 66.8 billion in 2024 and is projected to grow significantly to around US$ 198.9 billion by 2034, registering a CAGR of about 11.7% during the forecast period 2025-2034. This strong growth reflects the rapid shift toward digital and cashless payments, expanding e-commerce activity, and increasing demand for secure, fast, and seamless transaction processing across industries worldwide.
Payment processing solutions facilitate the authorization,…
Portable Diagnostics Devices Market Set for Steady Growth to USD 104.66 Million …
The Portable Diagnostics Devices Market reached USD 64.85 million in 2024 and is expected to reach USD 104.66 million by 2033, growing at a CAGR of 5.5% during the forecast period 2025-2033.
Market growth is driven by the rising demand for point-of-care testing, increasing prevalence of chronic diseases like diabetes and cardiovascular conditions, and the need for rapid, on-site diagnostics in remote or resource-limited settings. Advancements in miniaturization, biosensor technologies, and…
United States Solar Inverter And Battery Market is seeing strong growth at a CAG …
The Solar Inverter And Battery Market reached US$ 10.1 billion in 2022 and is expected to reach US$ 22.9 billion by 2030, growing with a CAGR of 10.8% during the forecast period 2024-2031.
DataM Intelligence unveils its latest report on the "Solar Inverter And Battery Market size 2026," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume,…
Anti-Inflammatory Drugs Market to Reach US$ 198.92 Billion by 2031, Driven by Ri …
According to DataM Intelligence, the global Anti-Inflammatory Drugs market reached US$ 102.72 billion in 2023 and is expected to reach US$ 198.92 billion by 2031, growing at a CAGR of 8.7% during the forecast period 2024-2031. This growth is propelled by the increasing global burden of inflammatory conditions such as arthritis, asthma, IBD, and COPD, strong demand for biologics and NSAIDs, rapid expansion of biosimilars improving affordability, advancements in targeted…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
